CytomX Therapeutics, Inc. 4
4 · CytomX Therapeutics, Inc. · Filed Dec 29, 2016
Insider Transaction Report
Form 4
HUMPHREY RACHEL
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2016-12-28$6.61/sh+15,117$99,994→ 15,117 total - Exercise/Conversion
Stock Option (Right to Buy)
2016-12-28−15,117→ 278,097 totalExercise: $6.61Exp: 2025-08-27→ Common Stock (15,117 underlying)
Footnotes (1)
- [F1]This option vests 25% on August 28, 2016, and the remaining 75% vests in 36 substantially equal monthly installments thereafter, with each additional installment vesting on the last day of the month, except the final installment, which shall vest on August 28, 2019.